{"id":"W2286173468","doi":"10.1200/jco.2015.63.8049","title":"Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition","year":2016,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"European Society for Medical Oncology; AstraZeneca Canada; American Society of Clinical Oncology","keywords":"Medicine; Cancer; Cancer research; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004814729,0.0004573181,0.002545542,0.001532548,0.0001866695,0.001558257,0.0008570902,0.0009922761,0.002836255],"category_scores_gemma":[0.007530761,0.0002157901,0.00188024,0.001688668,0.0005433653,0.001575975,0.0004572211,0.001638303,0.0004611454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001105042,"about_ca_system_score_gemma":0.003274473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001181402,"about_ca_topic_score_gemma":0.002645174,"domain_scores_codex":[0.9984543,0.0005138036,0.0003511028,0.0001681374,0.0004499658,0.00006263003],"domain_scores_gemma":[0.991051,0.006032278,0.001471212,0.0001572773,0.001113985,0.0001742498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007162409,0.00008487287,0.001152856,0.1644216,0.001365229,0.0001437071,0.00009962154,0.0007023052,0.00128675,0.002485881,0.01153174,0.8160091],"study_design_scores_gemma":[0.0008032397,0.002750548,0.009252819,0.2893562,0.008121029,0.001491522,0.0003822862,0.0007241398,0.001457578,0.006246605,0.6793352,0.00007876976],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002727407,0.9985461,0.00004817365,0.0007872413,0.0001143577,0.000006055248,0.00001833435,0.000003307576,0.0002036699],"genre_scores_gemma":[0.00525984,0.9929831,0.0002139837,0.001041885,0.0003231641,0.00001561414,0.00005271138,0.000002939654,0.0001066588],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004814729,"threshold_uncertainty_score":0.02546304,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06750101670510644,"score_gpt":0.5144393905794349,"score_spread":0.4469383738743284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}